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Abstract Recognition of myocardial injury after non-cardiac
surgery is difficult, since strong analgesics (e.g. opioids) can
mask anginal symptoms, and ECG abnormalities are subtle or
transient. Thorough knowledge of the pathophysiological
mechanisms is therefore essential. These mechanisms can be
subdivided into four groups: type I myocardial infraction
(MI), type II MI, non-ischaemic cardiac pathology, and non-
cardiac pathology. The incidence of type I MI in patients with
a clinical suspicion of perioperative acute coronary syndrome
(ACS) is 45–57%. This percentage is higher in patients with a
high likelihood ofMI such as patients with ST-elevation ACS.
Of note, the generalisability of this statement is limited due to
significant study limitations. Non-ischaemic cardiac patholo-
gy and non-cardiac pathology should not be overlooked as a
cause of perioperative myocardial injury (PMI). Especially
pulmonary embolism and dysrhythmias are a common phe-
nomenon, and may convey important prognostic value. Im-
plementation of routine postoperative troponin assessment
and accessible use of minimally invasive imaging should be
considered to provide adequate individualised therapy. Also,
addition of preoperative imaging may improve the stratifica-
tion of high-risk patients who may benefit from preoperative
or perioperative interventions.
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Introduction
Annually, over 200 million people undergo major non-cardiac
surgery worldwide [1]. Despite technical improvements and
increased patient monitoring, these procedures currently re-
main associated with high mortality and morbidity. Overall
30-day mortality exceeds 2 %, and reaches 6 % in high-risk
populations (e.g. certain vascular populations) [2–6]. Over
half of these deaths are attributable to adverse cardiovascular
events [3, 7].
Recognition of an adverse cardiovascular event in the
perioperative phase is difficult. Typical anginal symptoms
are often masked due of the use of strong analgesics (e.g.
opioids), and changes on the electrocardiogram are predomi-
nantly subtle or transient [3, 6, 8]. Moreover, the diagnostic
value of cardiac biomarkers such as cardiac troponin and
creatine kinase muscle and brain isotype (CK-MB) remains
controversial in the perioperative period, since factors such as
skeletal muscle damage, inflammation and renal insufficiency
interfere with serum levels [9]. An adequate and timely diag-
nosis is therefore frequently delayed, and subsequent therapy
may not be initiated at all.
In order to improve early recognition of perioperative
myocardial injury (PMI), thorough knowledge of its
pathophysiological mechanisms is required. In this arti-
cle we will elaborate these mechanisms, and review the
available evidence concerning perioperative myocardial
infarction (MI).
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PMI may originate from four distinct pathophysiological
mechanisms:
I. MI type I is caused by fissuring or rupturing of an
unstable coronary artery atherosclerotic plaque. Consec-
utive platelet activation and aggregation causes thrombus
formation that occludes the vessel, and induces myocar-
dial ischaemia [10]. Surgical patients are especially vul-
nerable to such adverse events due to a hypercoagulable
state in a setting of tachycardia, anaemia, intraoperative
hypotension, and postoperative hypertension [8].
II. MI type II is caused by either a haemodynamic equilib-
rium disturbance combined with the presence of signif-
icant coronary artery disease (CAD), a severe coronary
vasospasm, or endothelial dysfunction [8]. These mech-
anisms induce a myocardial oxygen supply–demand
mismatch that leads to a more generalised type of
myocardial ischaemia than type I [11]. Common peri-
operative factors that increase myocardial oxygen de-
mand include hypertension, tachycardia and elevated
levels of catecholamines [8]. Decreased myocardial ox-
ygen supply is attributable to blood loss, intraoperative
hypotension, anaemia, and/or coronary vasospasm [8].
Furthermore, an oxygen supply deficit may develop if
the coronary collateral blood supply falls short [12].
III. Non-ischaemic cardiac pathology [8, 10]. This group
can be subdivided into cardiac dysrhythmias, acute non-
ischaemic cardiomyopathies (e.g. cerebrally or stress-
induced), and inflammatory and/or infectious processes.
Presence of postoperative electrolyte disturbances,
inflammation, hypertension and myocardial ischaemia
catalyse the commencement of a dysrhythmia [13, 14].
Non-ischaemic causes other than dysrhythmias are rare,
yet can be provoked by certain factors commonly associ-
ated with major surgery or trauma (e.g. high stress levels
in case of a Takotsubo / stress-induced cardiomyopathy,
or a bacteraemia in case of an endocarditis) [15, 16].
IV. Non-cardiac causes such as pulmonary embolism (PE).
The perioperative phase is associated with prolonged
periods of immobilisation in a period of haemodynamic
changes. Therefore, ideal circumstances are present for
the formation of a venous thromboembolism, and/or a
pulmonary embolism [17, 18]. The incidence of non-
cardiac causes other than PE is low, and mainly restricted
to certain high-risk patients.
A combination of two or more pathophysiological mecha-
nisms is also possible. For instance, a myocardial oxygen
supply–demand mismatch (i.e. type II MI) may lead to
increased shear stress of an atherosclerotic plaque that
consecutively causes the plaque to fissure or rupture (i.e. type
I MI induction) [8, 10].
Literature
Angiographic, histological or alternative imaging studies
that provide an overview of the prevalence of all four
aetiological mechanisms of PMI are currently not avail-
able. Therefore, we have to extrapolate data from studies
that have focussed on subgroups. Myocardial infarction
type I and II will be emphasised, as myocardial ischaemia
has been suggested to be the main cause of postoperative
morbidity and mortality [3, 8].
Type I versus type II myocardial infarction
The incidence of ST-segment elevation myocardial infarction
(STEMI) after non-cardiac surgery ranges from 0.06 % to
1.5 %, and is therefore very low [11, 19, 20]. In contrast,
transient periods of ST depression are relatively common, as
incidences range from 0.6 % to 50 % (i.e. numbers vary based
on study population and the use of continuous or interval ECG
monitoring) [11, 20, 21]. The ST depressions have historically
been associated with type II MI, yet – especially in the
perioperative phase—merely provide a suggestion of the un-
derlying pathophysiological mechanism [11]. Routine postop-
erative measurement of cardiac biomarkers, which are highly
sensitive for myocardial damage and provide a broader diag-
nostic window than a non-continuous ECG, essentially suffers
from the same inability to provide evidence concerning the
pathophysiological mechanism [19, 22].
Four studies were conducted to assess the incidence of the
two types of myocardial infarction after surgery: two necropsy
studies and two angiographic studies (Table 1). Appraisal of
study relevance and validity is shown in Table 2, and the
results are shown in Table 3.
Dawood et al. [23] performed a histopathological analysis
of coronary arteries and myocardium of autopsy heart speci-
mens of patients who suffered either a fatal perioperative MI
(n=42), or a non-perioperative MI (n=25). Patients in the
former group were eligible for inclusion if they had suffered
an intraoperative MI, or a MI <30 days of elective or emer-
gency surgery. The latter group was characterised by evidence
of MI in a non-surgical phase (i.e. no surgery for at least
3 months prior to their infarction). Diagnostic criteria for MI
were based on laboratory biomarkers, clinical parameters (e.g.
chest pain and/or pulmonary oedema), and an electrocardio-
gram (ECG). Histological evidence of plaque rupture and
haemorrhage into the plaque cavity or into the lumen was
considered direct evidence of disruption of an unstable plaque
(type I MI). This was found in 55 % (95 % CI 40–70 %) of
patients with a fatal perioperative MI, and in 40 % of patients
with a fatal non-perioperative MI. Hence, no significant
differences between the two groups were reported regarding
type I MI. Intracoronary thrombus was found in 28 %.
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Cohen et al. [24] performed a necropsy study that
assessed the underlying pathophysiological mechanism
of a fatal postoperative MI <72 h of elective surgery (n=26).
The presence of plaque cap fissuring (i.e., disruption of a
fibrous cap), plaque haemorrhage, or luminal thrombus
containing plaque elements (e.g., cholesterol crystals and
lipid-laden macrophages) was considered evidence of plaque
rupture (i.e. type IMI). This was present in 46% (95%CI 27–
67 %) of patients. Thrombus was found in 35 %.
Gualandro et al. [25] performed a prospective angiograph-
ic study to assess the cardiac pathophysiological mecha-
nism in 120 patients with a clinical suspicion of acute
coronary syndrome (ACS)) within 30 days after non-
cardiac surgery. Results were compared with angiographic
data from 120 non-surgical patients with spontaneous
ACS, and 240 patients with stable CAD. Ambrose type
II eccentric lesions (Table 4) and complex morphological
features (Table 5) were considered evidence of type I MI
[26, 27]. In the postoperative group, these incidences
were 45 % (95 % CI 36–54 %) and 57 % (95 % CI 48-
66 %), respectively. These numbers were significantly higher
in the non-perioperative ACS group (57 % and 79 %, respec-
tively), and significantly lower in the stable CAD group (16%
and 32 %, respectively). Thrombus was reported in 7.5 %,
32.5 %, and 8.8 % for perioperative ACS, spontaneous ACS,
and stable CAD, respectively.
Berger et al. [28] performed a retrospective therapeutic
study to assess the best immediate intervention in 48 patients
referred for coronary angiography because of a suspicion of
acute coronary syndrome within 7 days after non-cardiac
surgery. All patients had ischaemic chest pain ≥30 min or
haemodynamic instability combined with typical ECG
changes. Evidence of type I MI was present in 90 % (95 %
CI 81 %–98 %) of patients, and intracoronary thrombus was
found in 63 %.
Table 1 Study design
Design 1 Design 2 Design 3 Design 4 Method
to define
MI
Dawood Necropsya Retrospective Aetiological Case
control
HPe
Cohen Necropsyb Retrospective Aetiological Cohort HPe
Gualandro In-vivoc Prospective Aetiological Case
control
CAGf,g




a Fatal intraoperative MI, or a MI <30 days after non-cardiac surgery
versus fatal non-perioperative MI
b Fatal postoperative MI ≤72 h after non-cardiac surgery
c Suspicion of ACS <30 days after non-cardiac surgery versus non-
perioperative ACS versus stable CAD
dReferred for CAG because of a suspicion of acute coronary syndrome
<7 days after non-cardiac surgery
e Histopathological evidence of unstable plaque with disruption
f Complex atherosclerotic plaque morphology based on Goldstein’s
criteria
g Ambrose type II eccentric lesions
h Intracoronary evidence of thrombus
Table 2 Appraisal
Generalisability Validity
Study design Domain Determinant Outcome Blinding Baseline Standard Routine screening Missing data
Dawood +/− + + + – – + – ?
Cohen +/− + + + + – + – ?
Gualandro + – + + + + + – +
Berger – + – – – +/− ? – ?
Study design Prospective aetiological study (+); retrospective aetiological study (+/−); other (−)
Domain Patients with a perioperative ACS: <7 days (+); >7 days (−)
DeterminantMethods to define type I MI well described: yes (+); no (−)
Outcome Angiographic or histopathological data well described: yes (+); no (−)
Blinding Blinding of assessor for clinical characteristics: present (+); absent (−); incomplete documentation (?)
Baseline Adequate description of angina, relevant comorbidities and prior cardiac adverse events, ECG characteristics, relevant drug use: 4/4
determinants (+); 3 determinants (+/−), <3 determinants (−)
Standard Use of angiographic or histopathological data in accordance to objectified principals: yes (+); no (−); insufficient description (?)
Routine screeningUse of routine diagnostic screening (routine ECG assessment, continuous ECGmonitoring or routine biomarker assessment) : yes (+);
no (−)
Missing data<10 % (+); >10 % (−); not mentioned (?)
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Non-ischaemic cardiac and extra-cardiac pathophysiological
mechanisms of PMI
PMI is not exclusively caused by myocardial infarction. It can
also be a result of non-ischaemic cardiac pathology (e.g.
dysrhythmias, acute non-ischaemic cardiomyopathies, and
inflammatory and/or infectious processes) and/or extracardiac
pathology (i.e. predominantly pulmonary embolisms).
Non-ischaemic cardiac pathology
The pathophysiology of the non-ischaemic causes of
PMI can be subdivided into cardiac dysrhythmias, acute
non-ischaemic cardiomyopathies (e.g. cerebrally or stress-
induced), and inflammatory and/or infectious processes.
A cardiac dysrhythmia after non-cardiac surgery is a
common phenomenon [14, 29]. Yet, available evidence is
predominantly based on retrospective studies using non-
continuous ECG monitoring. These studies have designated
atrial fibrillation (AF) as the most frequent arrhythmia,
affecting an average of 3–4 % of patients undergoing non-
cardiac surgery [14, 29]. An additional 3–4 % develop a
supraventricular tachycardia (SVT) other than AF. All dys-
rhythmias are associated with a worse outcome; a large
multicentre trial reported an increased risk of mortality
(adjusted odds ratio 1.72; 95 % CI, 1.59–1.86), longer
hospital stays (adjusted relative difference, +24.0 %; 95 %
CI 21.5–26.5 %), and increased hospitalisation costs (adjust-
ed difference, +$4177; 95 % CI $3764–4590). Perioperative
mortality directly resulting from a dysrhythmia is seldom
reported after non-cardiac surgery, and its incidence is
Table 3 Results









No CAD MI type I Presence of
thrombus
Dawood 42 100 % – – – – 95.3 % 4.7 % 55%a 28 %
Cohen 26 42.3 % – – – – 88 % 11.5 % 46%a 35 %
Gualandro 120 100 % 40.7 % 5.8 % 65.1 % 5.5 days – 5.8 % 45%b 7 %
57 %c
Berger 48 100 % 100 % 68.8 % 31.3 % 0.5 days 87.5 % 0 % 90%d 63 %
n Number of included patients with perioperative MI
MIMyocardial infarction
STE-ACS ST-segment-elevation acute coronary syndrome
NSTE-ACS Non ST-segment-elevation acute coronary syndrome
CAG Coronary angiography
CAD Coronary artery disease
- Data not available
a Histopathological evidence of unstable plaque with disruption
bAmbrose type II eccentric lesions
c Complex atherosclerotic plaque morphology based on Goldstein’s criteria
d Unknown
Table 4 Ambrose criteria [26]
Type Characteristics
Concentric Symmetric and smooth narrowing
Type I eccentric Asymmetric stenosis with smooth borders and
a broad neck
Type II eccentric Asymmetric stenosis in the form of a convex
intraluminal obstruction with a narrow neck due
to one or more overhanging edges or irregular
or scalloped borders, or both
Multiple
irregularities
Three or more serial, closely spaced narrowing or
severe diffuse irregularities within a vessel
Table 5 Criteria for complex lesions - Goldstein et al. [27]
- An intraluminal filling defect consistent with thrombus, defined as
abrupt vessel cutoff with persistence of contrast, or an intraluminal
filling defect in a vessel within or adjacent to a stenotic region with
surrounding homogeneous contrast opacification
- Plaque ulceration, defined by the presence of contrast and hazy contour
beyond the vessel lumen;
- Plaque irregularity (haziness), defined by irregular margins or
overhanging edges
- Impaired flow (TIMI flow<3, except lesions characteristic of chronic
total occlusion, identified as tapering lesions with multiple fine
collaterals)
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pragmatically believed to be lower than 0.6 % [30]. Fac-
tors associated with an increased risk of developing a
perioperative dysrhythmia include age, significant valvu-
lar disease, congestive heart failure, prior dysrhythmias,
myocardial ischaemia, and electrolyte disturbances [14].
Also, a (pro-dysrhythmogenic) myocardial contusion should
be considered in patients who have experienced blunt thoracic
trauma prior to hospitalisation [31].
A perioperative cerebrally or stress-induced cardiomyopathy
can be provoked by an acute cerebrovascular event (predomi-
nantly subarachnoid haemorrhage) and/or high preoperative
stress levels [15, 32]. Especially stress-induced cardiomyopa-
thies may clinically present as an acute coronary syndrome, as
characteristic ECG signs of a myocardial infarction may be
present, and cardiac biomarkers may be elevated [33]. The
incidence of such cardiomyopathies is low, and current evidence
mainly consists of case reports [15, 32, 34].
Postoperative infections and systemic inflammatory re-
sponse syndromes (SIRS) are a frequent complication of
surgery in general [16]. Yet, inflammation or infection of
cardiac structures (i.e. myocarditis, pericarditis or endo-
carditis) after non-cardiac procedures is rare, and chiefly
restricted to patients with prosthetic heart valves [35]. In
those patients, pathogens such as Staphylococcus aureus
are capable of causing acute valvular failure, which is
associated with a very poor prognosis [36].
Extracardiac pathology
The perioperative phase is associated with prolonged periods
of immobilisation and a hypercoagulable state. Therefore,
ideal conditions are present for the formation of a venous
thromboembolism and a pulmonary embolism (PE). Studies
regarding postoperative PE have mainly focussed on ortho-
paedic and oncological populations, in which the incidence of
symptomatic and fatal PE is approximately 1 % and 0.1 %,
respectively [17, 18, 37]. Asymptomatic PE is observed in 2–
4 %, and is therefore at least twice as common as its symp-
tomatic counterpart [38, 39]. Of note, these numbers are based
on studies using a ventilation/perfusion (V/Q) scan. Using
computed tomography pulmonary angiography (CTPA),
which has better spatial resolution and diagnostic accuracy
than a ventilation-perfusion (V/Q) scan, small (asymptomatic)
perfusion defects can be detected more accurately [40, 41]. If
these perfusion defects are taken into account, the incidence of
asymptomatic PE after non-cardiac surgery is expected to
exceed 4 % [37, 42, 43]. However, the clinical relevance of
small—mostly asymptomatic - perfusion defects has not yet
been fully determined [44].
Other acute extracardiac causes such as a postoperative
aortic dissection are very rare after non-cardiac surgery, and
should primarily be suspected in patients with relevant
extracardiac morbidities, or a high cardiovascular risk profile
(e.g. those with a (familial) history of aortic aneurysms/
dissections and/or connective tissue disorders such as Marfan
syndrome or Ehlers-Danlos syndrome) [45]. Postoperative
hypertension may—in these patients—lead to an increased
risk of an aortic dissection [45].
Discussion
The incidence of type I MI in patients who suffer a fatal
perioperative MI ranges from 45 to 55 % (Table 3). This is
not significantly different from the non-surgical patients with
fatalMI or sudden cardiac death, in which type IMI represents
50–80 % [23, 46, 47]. In patients with a clinical suspicion of
acute coronary syndrome after non-cardiac surgery, type I MI
is observed in 45–57 % (Table 3). This percentage is much
higher in patients with a high likelihood of MI, such as
patients presenting with ST-elevation ACS [28]. Of note, the
validity and generalisability of these results are retained due a
number of limitations (Table 2).
First, the study populations and designs of the aforemen-
tioned studies are not interchangeable (Table 1). Dawood
studied 42 patients with MI <30 days of elective or emergency
surgery using a case–control design, whilst Cohen studied 26
patients with MI <72 h after elective surgery using a cohort
design. Of note, the study populations and designs of the
angiographic studies were even less interchangeable: Gualandro
performed a prospective aetiological study that assessed the
incidence of type I MI in patients suspected of ACS, whilst
Berger performed a retrospective therapeutic study to assess the
best immediate invasive strategy in patients with an (almost
certain) perioperative MI (Table 1).
Second, the methods to define MI (Table 1) are
heterogenic; Dawood and Cohen used a histopathological
analysis (i.e. the gold standard), whilst the in-vivo studies
used conventional coronary angiography (CAG). A CAG
has high diagnostic accuracy for MI, yet a number of
limitations have to be recognised [48, 49]. For instance, its
interpretation is primarily based on the assessment of signif-
icant coronary lesions. Yet, a significant stenosis is not a
necessity for a type I MI, since normal angiographic find-
ings have been reported in 4–31 % of non-surgical pa-
tients with acute MI [48, 49]. In those cases, outward
remodelling of an unstable atherosclerotic plaque may
have only caused a slight, or even a non-existent coronary
lumen reduction [50]. The share of type I MI may thus be
underestimated.
Third, the incidence of clinical signs and symptoms sug-
gestive of MI varies between studies (Table 3); Cohen and
Gualandro reported incidences of 42.5 % and 41 %, respec-
tively. Berger reported anginal symptoms in 100 %, and
Dawood did not provide any numbers. The high incidence
reported byBerger reflects its methodological shortcomings to
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answer our clinical question. Moreover, it underlines the fact
that its population does not fully correspond to the average
population with a perioperative MI. The incidences reported
by Gualandro appear to be consistent with a large prospective
study that reported an incidence of ischaemic symptoms in
patients with perioperative non-fatal MI of 38.1 % [4]. How-
ever, Gualandro did not perform routine assessments of car-
diac biomarkers and/or continuous ECG monitoring. PMI
could therefore have been missed in patients using strong
analgesics. As a result, a clinically moderate group was stud-
ied, and the incidence of type I may have been overestimated.
This suggestion is supported by high numbers of multi- or
three-vessel disease (Table 3). Of note, the overestimation
may have been somewhat tempered by missing data from
critically ill patients who died before the angiography was
performed [25].
Fourth, the incidence of coronary thrombus differs be-
tween the angiographic studies; Gualandro reported 7 %
compared to 63 % reported by Berger (Table 3). The low
incidence found by Gualandro may have been related to the
long interval between the MI and the angiography (average
delay of 5.5 days versus 0.5 days in Gualandro versus
Berger, respectively), the use of statins, antiplatelet and
anticoagulant agents, and a lower likelihood of a type I MI
than Berger. All of these factors may have contributed to
(spontaneous) thrombolysis. The diagnostic delay can be
Table 6 Useful diagnostic modalities to determine the pathophysiology
of PMI
Type Characteristics
CAG Pro Best diagnostic accuracy for in-vivo
assessment of myocardial infarction. Gold
standard. Option of immediate assessment
of clinical significance of coronary stenoses
with FFR. Also, immediate PCI
is possible
Con Invasive, risk of iatrogenic coronary
dissection. Not attractive in the early
postoperative phase. Use of contrast fluid.
Radiation exposure. Expensive
IVUS Pro Assessment of both coronary lumen, and
plaque morphology (e.g. atheroma).
Assessment of unstable/vulnerable
plaques; plaque rupture, erosion, and
intracoronary thrombus. Especially useful
in situations in which angiographic imaging
is considered unreliable, such overlapping
vessels that cannot be adequately assessed
with CAG, and in case of outward plaque
remodelling
Con Expensive, invasive, time-consuming. Only
performed by specialised angiographers.
Use of contrast fluid. Radiation exposure.
Measurement difficulties in case of
bifurcations
OCT Pro Approximately 10 times higher resolution
than IVUS. Well suited for plaque
morphologies within 500 μm.
Furthermore, similar to IVUS
Con Vessel occlusion by means of gentle balloon
inflation, and vessel flushing with saline
during imaging acquisition is required.
Therefore, assessment of the left main
coronary artery might not be desirable.
Shallow penetration depth in comparison to
IVUS. Not appropriate for evaluation of
arterial remodelling. Furthermore, similar
to IVUS
Echocardiogram Pro Assessment of myocardial segmental wall
kinetics, right ventricular kinetics, and
valvular apparatus. No radiation exposure
Con Coronary and pulmonary arteries no
visualised, variable image quality
CCTA Pro Number and degree of coronary artery
stenoses, coronary calcifications, aspect of
coronary plaque. Possibility of obtaining
coronary artery calcium score
Con Artefacts due to calcifications. Pulmonary
arteries not or only partially visualised.
Overestimation of stenosis degree in
calcified plaques (blooming). Use of
contrast fluid. Radiation exposure
CTPA Pro Assessment of pulmonary arteries. Highly
sensitive for PE
Con Diagnosis of small perfusion defects with
unknown prognostic value. Coronaries and
heart are not accurately visualised. Use of
contrast fluid. Radiation exposure
Table 6 (continued)
Type Characteristics
Cardiac MRI Pro Highly sensitive for MI. Assessment of
myocardial contraction, and segmental wall
kinetics. No radiation exposure
Con Coronaries and pulmonary arteries not or only
partially visualised. Expensive, time-
consuming. Use of gadolinium
Cardiac adenosine
stress MRI
Pro Highly sensitive for MI. Assessment of
clinical significance of coronary stenoses
by generating chemically-induced
myocardial ischaemia.
Con Coronaries and pulmonary arteries not or only
partially visualised. Expensive, time-
consuming. Use of gadolinium. Use of
adenosine. Limited availability
PMI Perioperative Myocardial Injury
CAG Coronary Angiography
PCI Percutaneous Coronary Intervention
FFR Fractional Flow Reserve
IVUS Intravascular ultrasound
OCT Optical Coherence Tomography
CCTA Coronary Computed Tomography Angiography
PE Pulmonary Embolism
CTPA Computed Tomography Pulmonary Angiography
MRI Magnetic Resonance Imaging
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explained by the undesirability of coronary angiography in
the (very) early postoperative period, which is a result of its
invasive nature, and the necessity of administration of
antiplatelet agents and heparin.
Furthermore, the share of non-ischaemic and extracardiac
pathology may not be overlooked as a cause of PMI. Espe-
cially cardiac dysrhythmias and pulmonary embolisms are
common after noncardiac surgery, yet—as with periopera-
tive MI—frequently remain asymptomatic. Current studies
tend to be biased toward symptomatic cases that represent a
population with a worse prognosis. In case of pulmonary
embolisms, this is underlined by a high incidence of im-
paired right ventricular function, which correlates with a
higher risk of death within 3 months (hazard ratio 2.2
(95 % CI 1.4–3.4)) [17]. Increased accessibility of computed
tomography angiography (CTA) will lead to an increased
recognition of (asymptomatic) PE [51]. Yet, the clinical
relevance of small asymptomatic perfusion defects detected
by CTA is currently unknown and should be evaluated in
the near future [44].
Clinical signs and ECGs cannot guarantee early recog-
nition of PMI, and the implementation of standard contin-
uous ECG monitoring is difficult. Additional screening
therefore appears to be indispensable. This creates a win-
dow of opportunity for routine postoperative assessment of
biomarkers such as cardiac troponin (cTn), which has re-
cently shown to be a strong and independent predictor of
short- and intermediate-term mortality [3, 19, 22]. Its diag-
nostic interpretation, however, can be troublesome due to
the interference of renal dysfunction, cerebral pathology
and inflammation [9]. cTn can therefore not be used as
hard evidence of myocardial injury. Yet, it can be used to
stratify patients who could benefit from additional antico-
agulant therapy or a percutaneous coronary intervention
(PE/MI or MI, respectively). Non and minimally invasive
modalities (i.e. CTA, MRA and echocardiography) should
be accessibly used in the early postoperative phase to avoid
the use of superfluous anticoagulant and antiplatelet agents
that are a necessity during CAG. The most valuable diag-
nostic modality should be individually determined based on
the patient’s type of surgery, medical history, clinical pre-
sentation and comorbidities (Table 6).
Furthermore, the additive value of preoperative cardiac
imaging needs to be evaluated, since current clinical predic-
tion models convey prognostic value, yet frequently fail to
adequately predict PMI [52, 53]. Addition of modalities such
as a (coronary) CTA may improve prognostic values, and
could lead to a better stratification of patients who benefit
from additional preoperative or perioperative interventions
[54]. The relevance of such a selection is underlined by the
fact that a reduction in cardiac events can be counterbalanced
by an increased risk of cerebrovascular pathology or bleeding
(e.g. in case of antiplatelet agents) [4, 55].
Conclusion
Recognition of perioperative myocardial injury after non-
cardiac surgery is difficult due to the masking of angina, and
the subtlety or transiency of ECG abnormalities. Thorough
knowledge of the pathophysiologic mechanisms is therefore
essential. These mechanisms can be subdivided into four
groups: type I MI, type II MI, non-ischaemic cardiac pathol-
ogy, and non-cardiac pathology.
In patients suspected of a perioperative acute coronary
syndrome. The incidence of type I MI is 45-57 %; this per-
centage is higher in those with a high likelihood of MI such as
patients with ST-elevation ACS. Of note, the generalisability
of this statement is limited due to significant study limitations.
Non-ischaemic cardiac pathology and non-cardiac pathol-
ogy should not be overlooked as a cause of PMI. Especially
pulmonary embolisms and dysrhythmias are a common phe-
nomenon, and may convey important prognostic value. Im-
plementation of routine postoperative troponin assessment
and accessible use of minimally invasive imaging should be
considered to provide adequate individualised therapy. Also,
the addition of preoperative imaging may also improve
stratification of high-risk patients that will benefit from pre-
or perioperative interventions.
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